Rhumbline Advisers Raises Position in USANA Health Sciences, Inc. (NYSE:USNA)

Rhumbline Advisers lifted its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 39.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 49,390 shares of the company's stock after buying an additional 14,068 shares during the period. Rhumbline Advisers owned about 0.26% of USANA Health Sciences worth $1,773,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of USNA. R Squared Ltd acquired a new position in USANA Health Sciences during the fourth quarter worth about $28,000. Safe Harbor Fiduciary LLC purchased a new stake in shares of USANA Health Sciences during the 3rd quarter worth approximately $30,000. KBC Group NV grew its holdings in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company's stock worth $40,000 after acquiring an additional 519 shares during the period. Centiva Capital LP acquired a new position in USANA Health Sciences during the third quarter worth $213,000. Finally, Quest Partners LLC acquired a new stake in USANA Health Sciences in the third quarter valued at $250,000. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Stock Up 1.4 %

Shares of USNA traded up $0.44 on Friday, hitting $32.93. 235,379 shares of the stock traded hands, compared to its average volume of 176,186. The firm has a market capitalization of $627.70 million, a P/E ratio of 11.64, a P/E/G ratio of 0.93 and a beta of 0.98. USANA Health Sciences, Inc. has a 1 year low of $27.71 and a 1 year high of $50.32. The stock's 50 day moving average is $33.02 and its two-hundred day moving average is $36.27.

Remove Ads

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $213.61 million for the quarter, compared to analysts' expectations of $208.82 million. Research analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Buying and Selling

In related news, CEO Jim Brown sold 5,000 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total value of $147,350.00. Following the transaction, the chief executive officer now directly owns 15,716 shares of the company's stock, valued at approximately $463,150.52. This trade represents a 24.14 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company's stock.

Analyst Ratings Changes

USNA has been the topic of a number of research reports. Sidoti cut shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, February 18th. DA Davidson dropped their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research note on Thursday, February 27th. Finally, StockNews.com cut USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.